Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 894 articles:
HTML format



Single Articles


    April 2024
  1. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    PubMed    


  2. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    PubMed    


  3. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    PubMed    


  4. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    PubMed    


  5. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    PubMed    


  6. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    PubMed    


  7. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    PubMed    


  8. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    PubMed    


    March 2024
  9. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    PubMed    


  10. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    PubMed     Abstract available


  11. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    PubMed    


  12. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    PubMed     Abstract available


    February 2024
  13. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    PubMed    


  14. HSU NC, Hsu CH
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:729.
    PubMed    


  15. TAO L, Liu J
    The INSPIRE study: RSV infection during infancy.
    Lancet. 2024;403:728-729.
    PubMed    


  16. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    PubMed    


  17. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    PubMed    


  18. WANG X, Li Y, Shi T, Bont LJ, et al
    Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Lancet. 2024 Feb 14:S0140-6736(24)00138-7. doi: 10.1016/S0140-6736(24)00138.
    PubMed     Abstract available


  19. ADERINTO N, Olatunji G, Kokori E
    Health implications of GSK's departure from Nigeria.
    Lancet. 2024;403:526-527.
    PubMed    


    January 2024
  20. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
    The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
    PubMed     Abstract available


  21. WANG L, Wang Q, Gao GF
    Interpreting COVID-19 data from China: a call for caution - Authors' reply.
    Lancet. 2024;403:144-145.
    PubMed    


  22. QU Z
    Interpreting COVID-19 data from China: a call for caution.
    Lancet. 2024;403:144.
    PubMed    


  23. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    PubMed    



  24. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
    PubMed     Abstract available


  25. SHAH SA, Robertson C, Sheikh A
    Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
    Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
    PubMed    


    December 2023
  26. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
    Louis Pasteur, COVID-19, and the social challenges of epidemics.
    Lancet. 2023;400:2166-2168.
    PubMed    


  27. CHARLIER P
    Death and end of life in France after COVID-19.
    Lancet. 2023;402:2290.
    PubMed    


  28. HORTON R
    Offline: Boris Johnson and COVID-19-more light than heat.
    Lancet. 2023;402:2277.
    PubMed    


    November 2023
  29. GRABAR-KITAROVIC K, Phumaphi J
    A crisis of trust in pandemic prevention, preparedness, and response.
    Lancet. 2023;402:1730-1732.
    PubMed    


  30. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    PubMed     Abstract available


  31. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    PubMed     Abstract available



  32. Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    PubMed     Abstract available


  33. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    PubMed     Abstract available


  34. MARTIN A, Jamieson S
    Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    PubMed     Abstract available


  35. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
    Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    PubMed     Abstract available


  36. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    PubMed     Abstract available


  37. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
    Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    PubMed     Abstract available


  38. HAZIR SG, Ryan C, Moore A, Lewis C, et al
    The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    PubMed     Abstract available


  39. DU Z, Wang L, Bai Y, Pei Y, et al
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    PubMed     Abstract available


  40. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
    Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    PubMed     Abstract available


    October 2023
  41. WANG Q, Bowen A, Ho J, Zhang RM, et al
    SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
    Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
    PubMed    


  42. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
    Scientific advisory councils in the COVID-19 response.
    Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
    PubMed    


    September 2023
  43. MATUCHANSKY C
    Natural SARS-CoV-2 infection-induced immune protection against re-infection.
    Lancet. 2023;402:1131.
    PubMed    


  44. FLACCO ME, Martellucci CA, Manzoli L
    Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Lancet. 2023;402:1129.
    PubMed    


  45. YANG C, Lapp L, Tebbutt SJ
    Overcoming COVID-19 vaccine hesitancy hurdles.
    Lancet. 2023;402:1129-1130.
    PubMed    


  46. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
    Striving to afford free health care in Greece during COVID-19.
    Lancet. 2023;402:1128-1129.
    PubMed    


  47. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
    Long COVID in low-income and middle-income countries: the hidden public health crisis.
    Lancet. 2023;402:1115-1117.
    PubMed    


  48. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
    Lancet. 2023;402:1132.
    PubMed    


  49. QU Z
    Cautionary notes on the COVID-19 re-infection study.
    Lancet. 2023;402:1130-1131.
    PubMed    


  50. ZHOU YB, Xu ZG
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
    Lancet. 2023;402:1131-1132.
    PubMed    


  51. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
    Community COVID-19 response in WHO's European region.
    Lancet. 2023;402:1127.
    PubMed    


  52. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    PubMed    


  53. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    PubMed    


  54. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    PubMed    


    August 2023
  55. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    PubMed    


  56. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    PubMed    


  57. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    PubMed    


  58. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    PubMed     Abstract available


    July 2023
  59. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    PubMed    


  60. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    PubMed    


  61. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    PubMed    


    June 2023
  62. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
    Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
    Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
    PubMed    



  63. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed     Abstract available


  64. PELOSI A
    Disrespectful language about patients with long COVID.
    Lancet. 2023;401:2108.
    PubMed    


  65. PRIYA GIRI S, Dubey A
    Loneliness in the time of COVID-19: an alarming rise.
    Lancet. 2023;401:2107-2108.
    PubMed    


  66. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
    Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
    Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
    PubMed    


  67. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
    Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
    Lancet. 2023;401:2021-2023.
    PubMed    


  68. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    PubMed     Abstract available


  69. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed     Abstract available


  70. LAL A, Schwalbe N
    Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery.
    Lancet. 2023;401:1847.
    PubMed    


    May 2023
  71. JAFFE S
    US health experts divided on social media age restrictions.
    Lancet. 2023;401:1757.
    PubMed    



  72. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
    Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
    PubMed    


  73. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    PubMed    


  74. ZAROCOSTAS J
    With the COVID-19 PHEIC over, what next?
    Lancet. 2023;401:1642-1643.
    PubMed    


  75. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
    Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
    Lancet. 2023;401:1649.
    PubMed    


  76. JAFFE S
    US Surgeon General: loneliness is a public health crisis.
    Lancet. 2023;401:1560.
    PubMed    


  77. EMANUEL EJ, Persad G
    The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
    Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
    PubMed     Abstract available


    April 2023
  78. AGRAWAL U, Robertson C, Sheikh A
    Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
    Lancet. 2023;401:1424.
    PubMed    


  79. BRANCH-ELLIMAN W, Monach PA
    Moving towards a precision approach for prevention of severe COVID-19.
    Lancet. 2023;401:1423-1424.
    PubMed    


  80. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
    The importance of accountability in tackling future pandemics.
    Lancet. 2023;401:1423.
    PubMed    


  81. GALVAO J
    COVID-19: forgetting a pandemic that is not over.
    Lancet. 2023;401:1422-1423.
    PubMed    


  82. THE LANCET
    Moving past the COVID-19 emergency in the USA.
    Lancet. 2023;401:1399.
    PubMed    


  83. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
    Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
    PubMed     Abstract available


  84. CUENI T
    Lessons learned from COVID-19 to stop future pandemics.
    Lancet. 2023;401:1340.
    PubMed    


  85. HORTON R
    Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
    Lancet. 2023;401:1324.
    PubMed    


  86. LURIE N, Sharfstein JM
    State-to-state differences in US COVID-19 outcomes: searching for explanations.
    Lancet. 2023;401:1314-1315.
    PubMed    


  87. BILLARD MN, Bont LJ
    The link between respiratory syncytial virus infection during infancy and asthma during childhood.
    Lancet. 2023 Apr 19:S0140-6736(23)00672-4. doi: 10.1016/S0140-6736(23)00672.
    PubMed    


  88. ROSAS-SALAZAR C, Chirkova T, Gebretsadik T, Chappell JD, et al
    Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.
    Lancet. 2023 Apr 19:S0140-6736(23)00811-5. doi: 10.1016/S0140-6736(23)00811.
    PubMed     Abstract available


  89. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
    Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
    Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
    PubMed    


  90. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
    Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
    Lancet. 2023;401:e20.
    PubMed    


  91. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
    Characteristics of the omicron XBB subvariant wave in Singapore.
    Lancet. 2023;401:1261-1262.
    PubMed    


  92. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
    Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
    Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
    PubMed     Abstract available



  93. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
    PubMed     Abstract available


  94. PERNER A, Venkatesh B
    Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
    Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
    PubMed    


    March 2023
  95. SUN L, Jia H, Yang T
    Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1000.
    PubMed    


  96. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
    Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
    PubMed     Abstract available


  97. QU Z
    International cooperation to end the COVID-19 pandemic.
    Lancet. 2023;401:820.
    PubMed    


  98. THE LANCET
    Long COVID: 3 years in.
    Lancet. 2023;401:795.
    PubMed    



  99. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    Lancet. 2023;401:833-842.
    PubMed     Abstract available


  100. COHEN C, Pulliam J
    COVID-19 infection, reinfection, and the transition to endemicity.
    Lancet. 2023;401:798-800.
    PubMed    


  101. STOCKWELL M
    Effect of a nationwide intervention of electronic letters with behavioural nudges on influenza vaccination in older adults in Denmark.
    Lancet. 2023 Mar 3:S0140-6736(23)00453-1. doi: 10.1016/S0140-6736(23)00453.
    PubMed    


  102. JOHANSEN ND, Vaduganathan M, Bhatt AS, Lee SG, et al
    Electronic nudges to increase influenza vaccination uptake in Denmark: a nationwide, pragmatic, registry-based, randomised implementation trial.
    Lancet. 2023 Mar 3:S0140-6736(23)00349-5. doi: 10.1016/S0140-6736(23)00349.
    PubMed     Abstract available


  103. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
    Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
    Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
    PubMed    


    February 2023
  104. HUANG S, Gao Z, Wang S
    China's COVID-19 reopening measures-warriors and weapons.
    Lancet. 2023;401:643-644.
    PubMed    


  105. HAY SI, Murray CJL
    Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Lancet. 2023;401:433-434.
    PubMed    


  106. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432-433.
    PubMed    


  107. DONZELLI A
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432.
    PubMed    


  108. MOETI M, Makubalo L, Gueye AS, Balde T, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    PubMed    


  109. O'NEILL D
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    PubMed    


  110. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431-432.
    PubMed    


  111. PAN Y, Wang L, Feng Z, Xu H, et al
    Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
    PubMed     Abstract available


  112. PREISER W, Maponga T
    So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
    Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
    PubMed    


  113. TAN H, Liu J, Zeng F
    China needs a scientific long COVID recovery-support platform.
    Lancet. 2023;401:344-345.
    PubMed    


    January 2023
  114. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
    Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
    PubMed     Abstract available


  115. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
    Global and regional governance of One Health and implications for global health security.
    Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
    PubMed     Abstract available


  116. TRAORE T, Shanks S, Haider N, Ahmed K, et al
    How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
    Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
    PubMed     Abstract available


  117. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
    A global analysis of One Health Networks and the proliferation of One Health collaborations.
    Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
    PubMed     Abstract available


  118. ELLINGTON S, Jatlaoui TC
    COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
    Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
    PubMed    


  119. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
    Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
    PubMed     Abstract available


  120. THE LANCET
    The COVID-19 pandemic in 2023: far from over.
    Lancet. 2023;401:79.
    PubMed    


  121. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
    COVID-19 and other pandemics require a coherent response strategy.
    Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
    PubMed    


    December 2022
  122. TIBBLE H, Mueller T, Proud E, Hall E, et al
    Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
    Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
    PubMed    


  123. KIDD MR, Kelly PM
    PANORAMIC: important insights into molnupiravir use in COVID-19.
    Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
    PubMed    


  124. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
    Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
    PubMed     Abstract available


  125. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
    Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
    Lancet. 2022;400:2109-2124.
    PubMed     Abstract available


  126. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
    Racism, xenophobia, discrimination, and the determination of health.
    Lancet. 2022;400:2097-2108.
    PubMed     Abstract available


  127. ELSON W, Zambon M, de Lusignan S
    Integrated respiratory surveillance after the COVID-19 pandemic.
    Lancet. 2022;400:1924-1925.
    PubMed    


    November 2022
  128. JAFFE S
    US CDC begins agency-wide changes after pandemic failures.
    Lancet. 2022;400:1754-1755.
    PubMed    


  129. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    PubMed    


  130. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
    Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
    Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
    PubMed     Abstract available


  131. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
    WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
    PubMed    


  132. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    PubMed     Abstract available


    October 2022

  133. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
    PubMed     Abstract available


  134. FRENK J, Chen LC, Chandran L, Groff EOH, et al
    Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
    Lancet. 2022;400:1539-1556.
    PubMed     Abstract available


  135. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
    PubMed    


  136. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
    The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
    Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
    PubMed    


  137. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
    After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
    Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
    PubMed    


  138. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
    Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2022;400:1305-1320.
    PubMed     Abstract available


  139. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
    Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
    Lancet. 2022;400:1304.
    PubMed    


  140. IRVING SA, Sundaram ME
    Prioritisation of COVID-19 boosters in the omicron era.
    Lancet. 2022;400:1282-1283.
    PubMed    


  141. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    PubMed     Abstract available


  142. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    PubMed    


  143. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
    A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
    Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
    PubMed    


  144. WU MY, Carr EJ, Harvey R, Mears HV, et al
    WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
    Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
    PubMed    


    September 2022
  145. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
    Characterising adults in Scotland who are not vaccinated against COVID-19.
    Lancet. 2022;400:993-995.
    PubMed    


  146. ZIEGLER T, Moen A, Zhang W, Cox NJ, et al
    Global Influenza Surveillance and Response System: 70 years of responding to the expected and preparing for the unexpected.
    Lancet. 2022;400:981-982.
    PubMed    


  147. THE LANCET
    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    PubMed    


  148. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    PubMed    


  149. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    PubMed    


  150. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    PubMed    


  151. ZHANG Y, Wang Y, Ning G, He P, et al
    Protecting older people: a high priority during the COVID-19 pandemic.
    Lancet. 2022;400:729-730.
    PubMed    


  152. THORNTON J
    New centre for pandemic therapeutics.
    Lancet. 2022;400:722.
    PubMed    


    August 2022
  153. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Influenza.
    Lancet. 2022;400:693-706.
    PubMed     Abstract available


  154. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    PubMed    


  155. PICKERSGILL M, Manda-Taylor L, Nino-Machado N
    Pandemic preparedness means policy makers need to work with social scientists.
    Lancet. 2022;400:547-549.
    PubMed    


  156. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    PubMed     Abstract available


  157. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    PubMed    


  158. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    PubMed    


  159. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    PubMed    


    July 2022

  160. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    PubMed     Abstract available


  161. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    PubMed    


  162. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    PubMed    


  163. DALZIEL SR, Haskell L, O'Brien S, Borland ML, et al
    Bronchiolitis.
    Lancet. 2022;400:392-406.
    PubMed     Abstract available


  164. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    PubMed    


  165. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    PubMed    


  166. DURRHEIM DN
    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    PubMed    


  167. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    PubMed    


  168. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    PubMed    


  169. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    PubMed    


  170. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    PubMed    


  171. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    PubMed    


    June 2022
  172. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    PubMed     Abstract available


  173. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    PubMed    


  174. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    PubMed    


  175. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    PubMed    


  176. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    PubMed    


  177. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    PubMed     Abstract available


  178. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    PubMed     Abstract available


  179. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    PubMed    


  180. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    PubMed    


    May 2022
  181. HARTERT TV, Ortiz JR
    Need for improved global measurement of early childhood respiratory syncytial virus disease.
    Lancet. 2022;399:1993-1995.
    PubMed    


  182. LI Y, Wang X, Blau DM, Caballero MT, et al
    Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Lancet. 2022;399:2047-2064.
    PubMed     Abstract available


  183. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    PubMed    


  184. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    PubMed    


  185. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    PubMed    


  186. HORTON R
    Offline: How to fix pandemic preparedness.
    Lancet. 2022;399:1927.
    PubMed    


  187. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    PubMed     Abstract available


  188. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    PubMed    


  189. SHERLOCK PL
    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    PubMed    


  190. THE LANCET
    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    PubMed    


  191. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    PubMed    


  192. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    PubMed    


  193. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    PubMed    


  194. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    PubMed     Abstract available



  195. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    PubMed     Abstract available


    April 2022
  196. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    PubMed    


  197. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    PubMed     Abstract available


  198. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    PubMed    


  199. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    PubMed    


  200. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    PubMed     Abstract available


  201. NTOUMI F, Zumla A
    Advancing accurate metrics for future pandemic preparedness.
    Lancet. 2022;399:1443-1445.
    PubMed    


  202. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    PubMed    


  203. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    PubMed    


  204. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    PubMed    


  205. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    PubMed    



  206. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    PubMed     Abstract available


  207. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    PubMed    


  208. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    PubMed     Abstract available


  209. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    PubMed    


  210. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    PubMed     Abstract available


  211. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    PubMed     Abstract available


  212. ZAROCOSTAS J
    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    PubMed    


  213. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    PubMed    


  214. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    PubMed    


    March 2022
  215. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    PubMed     Abstract available


  216. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    PubMed    


  217. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    PubMed    



  218. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    PubMed     Abstract available


  219. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    PubMed    


  220. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    PubMed    


  221. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed    


  222. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available


  223. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    PubMed     Abstract available


  224. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    PubMed    


  225. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    PubMed     Abstract available


  226. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    PubMed    


  227. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    PubMed     Abstract available


  228. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    PubMed    



  229. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    PubMed     Abstract available


  230. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    PubMed    


  231. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    PubMed    


  232. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    PubMed    


  233. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    PubMed     Abstract available


  234. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    PubMed    


    February 2022
  235. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    PubMed    


  236. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    PubMed    


  237. THE LANCET
    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    PubMed    



  238. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    PubMed     Abstract available


  239. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    PubMed    


  240. PIECHOTTA V, Harder T
    Waning of COVID-19 vaccine effectiveness: individual and public health risk.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
    PubMed    


  241. FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
    Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
    PubMed     Abstract available


  242. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    PubMed    


  243. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    PubMed    


  244. DINEEN K, Autzen B, Alwan NA
    Children, intersectionality, and COVID-19.
    Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
    PubMed    


  245. SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
    Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
    Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
    PubMed     Abstract available


  246. EGGER S, Egger G
    The vaccinated propor-tion of people with COVID-19 needs context.
    Lancet. 2022;399:627.
    PubMed    


  247. MUSSINI C, Cozzi-Lepri A
    Another piece in the COVID-19 treatment puzzle.
    Lancet. 2022;399:609-610.
    PubMed    


  248. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    PubMed    



  249. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2022;399:665-676.
    PubMed     Abstract available


  250. LOPEZ A, Srigley J
    Transmission of SARS-CoV-2: still up in the air.
    Lancet. 2022;399:519.
    PubMed    


  251. GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
    Transmission of SARS-CoV-2: still up in the air - Authors' reply.
    Lancet. 2022;399:519-520.
    PubMed    


  252. DALY M, Robinson E
    Depression and anxiety during COVID-19.
    Lancet. 2022;399:518.
    PubMed    


  253. SANTOMAURO DF, Whiteford HA, Ferrari AJ
    Depression and anxiety during COVID-19 - Authors' reply.
    Lancet. 2022;399:518-519.
    PubMed    


  254. SAMARASEKERA U
    Ayoade Alakija: advancing equity in the COVID-19 response.
    Lancet. 2022;399:511.
    PubMed    


  255. ZAROCOSTAS J
    WHO concerned over COVID-19 health-care waste.
    Lancet. 2022;399:507.
    PubMed    


  256. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    PubMed    


  257. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    PubMed    


  258. THE LANCET
    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    PubMed    


  259. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    PubMed    


  260. NORDSTROM P, Ballin M, Nordstrom A
    Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
    PubMed     Abstract available


  261. KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
    COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
    PubMed    



  262. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
    PubMed     Abstract available


    January 2022
  263. HOLT E
    Polish Government COVID-19 advisors resign.
    Lancet. 2022;399:424.
    PubMed    


  264. NEALON J, Cowling BJ
    Omicron severity: milder but not mild.
    Lancet. 2022;399:412-413.
    PubMed    


  265. ADAMS R
    Urgent care: disability, pandemic, and the value of a life.
    Lancet. 2022;399:430-431.
    PubMed    


  266. JAFFE S
    The next steps for US vaccine mandates.
    Lancet. 2022;399:425-426.
    PubMed    


  267. SO-OSMAN C, Valk SJ
    High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
    PubMed    



  268. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
    PubMed     Abstract available


  269. HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
    Measles.
    Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
    PubMed     Abstract available


  270. FENDLER A, Shepherd STC, Au L, Wu M, et al
    Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
    PubMed    


  271. TANG TB
    The COVID-19 response in Hong Kong.
    Lancet. 2022;399:357.
    PubMed    


  272. ALFIERI C, Egrot M, Desclaux A, Sams K, et al
    Recognising Italy's mistakes in the public health response to COVID-19.
    Lancet. 2022;399:357-358.
    PubMed    


  273. QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
    Intersectionality and developing evidence-based policy.
    Lancet. 2022;399:355-356.
    PubMed    


  274. BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
    Long COVID and self-management.
    Lancet. 2022;399:355.
    PubMed    


  275. LANE R
    Jamal Rifi: family doctor building bridges in the community.
    Lancet. 2022;399:353.
    PubMed    


  276. COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
    Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
    PubMed     Abstract available


  277. BRAVO L, Smolenov I, Han HH, Li P, et al
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
    PubMed     Abstract available


  278. VESIKARI T
    Trimeric S protein COVID-19 vaccine needs to find its place.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
    PubMed    


  279. CARR EJ, Wu M, Harvey R, Billany RE, et al
    Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
    PubMed    


  280. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    PubMed     Abstract available


  281. MURRAY CJL
    COVID-19 will continue but the end of the pandemic is near.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
    PubMed    


  282. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    PubMed    


  283. KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
    Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
    PubMed    


  284. LAXMINARAYAN R
    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    PubMed    


  285. VALAIYAPATHI R, Wu MS, McGregor A
    Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
    Lancet. 2022;399:270.
    PubMed    


  286. PUNTIS JWL
    The UK People's Covid Inquiry.
    Lancet. 2022;399:236.
    PubMed    


  287. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    PubMed    


  288. HARMAN S
    The wall.
    Lancet. 2022;399:136-137.
    PubMed    


  289. BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
    COVID-19 ARDS: getting ventilation right - Authors' reply.
    Lancet. 2022;399:22-23.
    PubMed    


  290. PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
    COVID-19 ARDS: getting ventilation right.
    Lancet. 2022;399:22.
    PubMed    


  291. HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
    Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
    Lancet. 2022;399:21-22.
    PubMed    


  292. THE LANCET
    The state of science and society in 2022.
    Lancet. 2022;399:1.
    PubMed    


    December 2021
  293. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
    PubMed    


  294. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    PubMed     Abstract available


  295. KENNEDY RB
    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
    PubMed    


  296. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
    PubMed    


  297. LEUNG K, Wu JT
    Managing waning vaccine protection against SARS-CoV-2 variants.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
    PubMed    


  298. KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
    Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
    PubMed     Abstract available


  299. DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
    Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
    PubMed    


  300. PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
    Diagnostics for COVID-19: moving from pandemic response to control.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
    PubMed     Abstract available


  301. THE LANCET
    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    PubMed    


  302. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    PubMed    


  303. DANIELS JP
    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    PubMed    


  304. HALL V, Hopkins S
    COV-BOOST: evidence to support rapid booster deployment.
    Lancet. 2021;398:2209-2211.
    PubMed    


  305. THE LANCET
    COVID-19: where do we go from here?
    Lancet. 2021;398:2207.
    PubMed    


  306. MOLLICA RF, Fricchione GL
    Mental and physical exhaustion of health-care practitioners.
    Lancet. 2021;398:2243-2244.
    PubMed    


  307. ZAROCOSTAS J
    WHO and World Bank urge spending for UHC.
    Lancet. 2021;398:2223.
    PubMed    


  308. DEVI S
    Russia-Ukraine tensions hampering health-care access.
    Lancet. 2021;398:2222.
    PubMed    


  309. COVIDSURG COLLABORATIVE
    Projecting COVID-19 disruption to elective surgery.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
    PubMed    


  310. MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
    COVID-19 vaccine strategies must focus on severe disease and global equity.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
    PubMed    


  311. BRADBURY CA, McQuilten Z
    Anticoagulation in COVID-19.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
    PubMed    


  312. RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
    PubMed     Abstract available


  313. LIPWORTH B, Chan R, Misirovs R
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2147.
    PubMed    


  314. HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
    High-dose budesonide for early COVID-19 - Authors' reply.
    Lancet. 2021;398:2147-2148.
    PubMed    


  315. BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2146-2147.
    PubMed    


  316. THE LANCET
    Preventing violence against women: beyond 16 days.
    Lancet. 2021;398:2125.
    PubMed    


  317. MOON S, Armstrong J, Hutler B, Upshur R, et al
    Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
    Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
    PubMed     Abstract available


  318. RICHARDSON CD
    Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
    PubMed    


  319. STUART ASV, Shaw RH, Liu X, Greenland M, et al
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
    PubMed     Abstract available


  320. DEVI S
    Health warnings over UNRWA funding shortfall.
    Lancet. 2021;398:2063.
    PubMed    


  321. ZAROCOSTAS J
    Hope for nutrition summit as global hunger spikes.
    Lancet. 2021;398:2061-2062.
    PubMed    


  322. WARD H, Flower B, Garcia PJ, Ong SWX, et al
    Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
    Lancet. 2021;398:2057-2059.
    PubMed    


  323. KARIM SSA, Karim QA
    Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
    PubMed    


  324. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    PubMed    


  325. MUNRO APS, Janani L, Cornelius V, Aley PK, et al
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
    PubMed     Abstract available


    November 2021
  326. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    PubMed    


  327. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    COVID-19 and myocardial infarction - Authors' reply.
    Lancet. 2021;398:1964.
    PubMed    


  328. SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
    Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Lancet. 2021;398:1963.
    PubMed    


  329. CALDEIRA D, Pinto FJ
    COVID-19 and myocardial infarction.
    Lancet. 2021;398:1963-1964.
    PubMed    


  330. BOUM Y
    Beyond COVID-19: scaling up and sustaining mobile health in Africa.
    Lancet. 2021;398:1962-1963.
    PubMed    


  331. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    PubMed    


  332. SMITH K, Brooks W, Challiner J, Povey E, et al
    Quality assurance of remote clinical assessments in the NHS.
    Lancet. 2021;398:1962.
    PubMed    


  333. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    PubMed    


  334. FLEMING KA, Horton S, Wilson ML, Atun R, et al
    The Lancet Commission on diagnostics: transforming access to diagnostics.
    Lancet. 2021;398:1997-2050.
    PubMed    


  335. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    PubMed    


  336. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    PubMed    


  337. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    PubMed    


  338. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    PubMed    


  339. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    PubMed    


  340. KNEEBONE R, Houstoun W, Houghton N
    Medicine, magic, and online performance.
    Lancet. 2021;398:1868-1869.
    PubMed    


  341. BURKI T
    mRNA discoveries earn the 2021 Prince Mahidol Award.
    Lancet. 2021;398:1865.
    PubMed    


  342. SPYROPOULOS AC, Bonaca MP
    Studying the coagulopathy of COVID-19.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
    PubMed    



  343. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
    PubMed     Abstract available


  344. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    PubMed     Abstract available


  345. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    PubMed     Abstract available


  346. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    PubMed    


  347. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    PubMed     Abstract available


  348. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    PubMed     Abstract available


  349. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    PubMed    


  350. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.
    PubMed    


  351. MCMULLEN AM
    The choice to love.
    Lancet. 2021;398:1680-1681.
    PubMed    


  352. USHER AD
    New budget and strategy for ACT-A.
    Lancet. 2021;398:1677.
    PubMed    


  353. ZAROCOSTAS J
    WHO's Tedros set to be re-elected unopposed.
    Lancet. 2021;398:1676.
    PubMed    


  354. THE LANCET
    Can digital technologies improve health?
    Lancet. 2021;398:1663.
    PubMed    


  355. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    PubMed    


  356. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    PubMed     Abstract available


    October 2021
  357. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.
    PubMed    


  358. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.
    PubMed    


  359. DANIELS JP
    Nicaraguan health-care workers under attack.
    Lancet. 2021;398:1555-1556.
    PubMed    


  360. BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
    The World Health Network: a global citizens' initiative.
    Lancet. 2021;398:1567-1568.
    PubMed    


  361. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    PubMed     Abstract available


  362. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    PubMed    


  363. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
    PubMed    


  364. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    PubMed     Abstract available


  365. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.
    PubMed    


  366. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.
    PubMed    


  367. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.
    PubMed    



  368. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.
    PubMed    


  369. RICCIARDI W, Tarricone R
    The evolution of the Italian National Health Service.
    Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
    PubMed     Abstract available


  370. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
    PubMed    


  371. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    PubMed    


  372. LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
    Lancet. 2021;398:1304.
    PubMed    


  373. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
    Lancet. 2021;398:1303-1304.
    PubMed    


  374. MYERS SS, Pivor JI, Saraiva AM
    The Sao Paulo Declaration on Planetary Health.
    Lancet. 2021;398:1299.
    PubMed    


  375. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
    PubMed    



  376. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    PubMed     Abstract available


  377. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
    PubMed    


  378. KLEINERT S, Horton R
    Can COVID-19 help accelerate and transform the diagnostics agenda?
    Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
    PubMed    


  379. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    PubMed    


  380. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    PubMed     Abstract available


  381. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
    PubMed    


  382. TORRES I, Profeta B, Machado CV, Artaza O, et al
    COVID-19 research in LMICs - Authors' reply.
    Lancet. 2021;398:1213.
    PubMed    


  383. SISA I, Fornasini M, Teran E
    COVID-19 research in LMICs.
    Lancet. 2021;398:1212-1213.
    PubMed    


  384. VUYLSTEKE A
    ECMO in COVID-19: do not blame the tool.
    Lancet. 2021;398:1197-1199.
    PubMed    


  385. BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
    Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
    Lancet. 2021;398:1230-1238.
    PubMed     Abstract available


  386. VINER RM, Koirala A
    Daily antigen testing to reduce disruption when schools return.
    Lancet. 2021;398:1196-1197.
    PubMed    


    September 2021
  387. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
    PubMed    


  388. THE LANCET
    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.
    PubMed    


  389. AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
    Functioning of the International Health Regulations during the COVID-19 pandemic.
    Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
    PubMed    


  390. OGBUOJI O, Mao W, Aryeetey G
    The long-term impact of COVID-19 on development assistance for health is still uncertain.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
    PubMed    



  391. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
    PubMed     Abstract available


  392. WU Z, Jin Q, Wu G, Lu J, et al
    SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
    PubMed    


  393. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    PubMed    


  394. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    PubMed    


  395. SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
    Uncoupling vaccination from politics: a call to action.
    Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
    PubMed    


  396. YOUNG BC, Eyre DW, Kendrick S, White C, et al
    Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
    PubMed     Abstract available


  397. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    PubMed    


  398. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    PubMed    


  399. DANIELS JP
    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.
    PubMed    


  400. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    PubMed    


  401. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    PubMed     Abstract available


  402. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    PubMed    


  403. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    PubMed    


  404. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.
    PubMed    


  405. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    PubMed    


  406. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    PubMed    


    August 2021
  407. THE LANCET
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    PubMed    


  408. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    PubMed    


  409. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    PubMed    


  410. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    PubMed     Abstract available


  411. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    PubMed     Abstract available


  412. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    PubMed     Abstract available


  413. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    PubMed    


  414. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    PubMed    


  415. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    PubMed    


  416. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    PubMed    


  417. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    PubMed    


  418. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    PubMed    


  419. LIJFERING WM
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    PubMed    


  420. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    PubMed    


  421. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    PubMed    


  422. ADEPOJU P
    West Africa on alert for haemorrhagic fevers.
    Lancet. 2021;398:653.
    PubMed    


  423. USHER AD
    Health leaders criticise limited ACT-A review.
    Lancet. 2021;398:650-651.
    PubMed    


  424. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    PubMed    



  425. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    PubMed     Abstract available


  426. THORNTON J
    Focusing on island health.
    Lancet. 2021;398:569-570.
    PubMed    


  427. DANIELS JP
    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    PubMed    


  428. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    PubMed    


  429. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    PubMed    


  430. ETIENNE CF
    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    PubMed    


  431. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    PubMed    


  432. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    PubMed    


  433. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    PubMed    


  434. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    PubMed    


  435. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    PubMed    


  436. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    PubMed     Abstract available


  437. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    PubMed    


  438. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    PubMed    


  439. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    PubMed    


  440. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    PubMed    


  441. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    PubMed    


  442. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    PubMed    


  443. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    PubMed    


  444. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    PubMed    


  445. BELDA-INIESTA C
    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    PubMed    


  446. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    PubMed     Abstract available


  447. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    PubMed    


    July 2021
  448. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    PubMed    


  449. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    PubMed    


  450. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    PubMed    


  451. IJSSELMUIDEN C, Ntoumi F, Lavery JV, Montoya J, et al
    Should global financing be the main priority for pandemic preparedness?
    Lancet. 2021;398:388.
    PubMed    


  452. THE LANCET
    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.
    PubMed    


  453. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    PubMed    


  454. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    PubMed    


  455. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    PubMed     Abstract available


  456. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.
    PubMed    


  457. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.
    PubMed    


  458. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.
    PubMed    


  459. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.
    PubMed    


  460. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    PubMed    


  461. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    PubMed    


  462. THE LANCET
    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.
    PubMed    


  463. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    PubMed    


  464. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    PubMed    


  465. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    PubMed     Abstract available


  466. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    PubMed     Abstract available


  467. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.
    PubMed    


  468. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.
    PubMed    


  469. IDROVO AJ
    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.
    PubMed    


  470. THE LANCET
    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    PubMed    


  471. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    PubMed    


  472. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
    PubMed    


  473. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    PubMed    


  474. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    PubMed     Abstract available


  475. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    WHO COVID-19 therapeutic guidelines - Authors' reply.
    Lancet. 2021;398:118.
    PubMed    


  476. ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
    WHO COVID-19 therapeutic guidelines.
    Lancet. 2021;398:117-118.
    PubMed    


  477. ALSABA K
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
    Lancet. 2021;398:116.
    PubMed    


  478. NABETH P, Hassan M, Adib K, Abubakar A, et al
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
    Lancet. 2021;398:116-117.
    PubMed    


  479. THE LANCET
    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    PubMed    


  480. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.
    PubMed    


  481. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.
    PubMed    


  482. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    PubMed     Abstract available


  483. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    PubMed    


  484. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
    PubMed    


  485. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    PubMed     Abstract available


  486. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    PubMed    


  487. THORNTON J
    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    PubMed    


  488. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    PubMed    


  489. THE LANCET
    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    PubMed    


  490. KICKBUSCH I, Leung GM, Shattock RJ
    Learning from crisis: building resilient systems to combat future pandemics.
    Lancet. 2021;398:e2-e6.
    PubMed    


  491. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    PubMed     Abstract available


    June 2021
  492. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    PubMed    


  493. KUMAR D, Mittal M
    India's COVID-19 emergency: overarching conclusions belie facts.
    Lancet. 2021;397:2465.
    PubMed    


  494. SAHA K
    Can India's COVID-19 emergency be fixed without politics?
    Lancet. 2021;397:2465-2466.
    PubMed    


  495. VISARIA A, Dharamdasani T
    The complex causes of India's 2021 COVID-19 surge.
    Lancet. 2021;397:2464.
    PubMed    


  496. RADHAKRISHNAN N, Gupta DK
    India's COVID-19 response: science first.
    Lancet. 2021;397:2464-2465.
    PubMed    


  497. DUTTA R, Kucchal T
    India's pain: beyond COVID-19 case numbers and mortality rates.
    Lancet. 2021;397:2463.
    PubMed    


  498. DANIELS JP
    Colombians protest over inequities and health care.
    Lancet. 2021;397:2454.
    PubMed    


  499. DUARTE-SALLES T, Prieto-Alhambra D
    Heterologous vaccine regimens against COVID-19.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
    PubMed    


  500. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    PubMed    


  501. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    PubMed     Abstract available


  502. THE LANCET
    Protecting refugees during the COVID-19 pandemic.
    Lancet. 2021;397:2309.
    PubMed    


  503. BARRON GC, Koonin J
    A call to action on UHC commitments.
    Lancet. 2021;397:2335-2336.
    PubMed    


  504. USHER AD
    A beautiful idea: how COVAX has fallen short.
    Lancet. 2021;397:2322-2325.
    PubMed    


  505. KC S, Ananthakrishnan A, Painter C, Butani D, et al
    Research collaboration is needed to inform quarantine policies for health-care workers.
    Lancet. 2021;397:2334.
    PubMed    


  506. ABECASSIS A
    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
    PubMed    


  507. SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
    Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
    PubMed    


  508. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.
    PubMed    


  509. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.
    PubMed    


  510. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.
    PubMed    


  511. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.
    PubMed    


  512. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.
    PubMed    


  513. GUBRIUM A, Gubrium E
    Narrative complexity in the time of COVID-19.
    Lancet. 2021;397:2244-2245.
    PubMed    


  514. BERGER JS, Connors JM
    Anticoagulation in COVID-19: reaction to the ACTION trial.
    Lancet. 2021;397:2226-2228.
    PubMed    


  515. MCLELLAN F
    Kirsten Ostherr: mobilising the translational humanities.
    Lancet. 2021;397:2243.
    PubMed    


  516. THE LANCET
    We need a global conversation on the 2020 Olympic Games.
    Lancet. 2021;397:2225.
    PubMed    


  517. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
    PubMed    


  518. EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
    From routine data collection to policy design: sex and gender both matter in COVID-19.
    Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
    PubMed    


  519. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    PubMed    


  520. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    PubMed    


  521. ZAROCOSTAS J
    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    PubMed    


  522. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    PubMed    


  523. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    PubMed    


  524. USHER AD
    ACT Accelerator strains donors' aid budgets.
    Lancet. 2021;397:2137.
    PubMed    


  525. LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
    Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
    PubMed     Abstract available


  526. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
    PubMed    


  527. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    PubMed    


  528. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    PubMed    


    May 2021
  529. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    PubMed    


  530. TATUM M
    Cambodia ends controversial COVID-19 restrictions.
    Lancet. 2021;397:2035.
    PubMed    


  531. DEVI S
    Yemen's health system has "collapsed", warns UN.
    Lancet. 2021;397:2036.
    PubMed    


  532. DEVI S
    800 000 South Sudanese to lose access to health care.
    Lancet. 2021;397:2034.
    PubMed    


  533. AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
    India's resurgence of COVID-19: urgent actions needed.
    Lancet. 2021 May 25. pii: S0140-6736(21)01202.
    PubMed    



  534. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    PubMed     Abstract available


  535. JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
    Refugee access to COVID-19 vaccines in Lebanon.
    Lancet. 2021;397:1884.
    PubMed    


  536. NESAMONEY SN, Darmstadt GL, Wise PH
    Gendered effects of COVID-19 on young girls in regions of conflict.
    Lancet. 2021;397:1880-1881.
    PubMed    


  537. ZAROCOSTAS J
    What next for a COVID-19 intellectual property waiver?
    Lancet. 2021;397:1871-1872.
    PubMed    


  538. KIRENGA BJ, Byakika-Kibwika P
    Excess COVID-19 mortality among critically ill patients in Africa.
    Lancet. 2021;397:1860-1861.
    PubMed    


  539. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.
    PubMed    


  540. SAMARASEKERA U
    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    PubMed    


  541. HUANG L, Gu X, Wang Y, Huang C, et al
    Long-term effects of COVID-19 on kidney function - Authors' reply.
    Lancet. 2021;397:1807-1808.
    PubMed    


  542. WATSON SI
    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.
    PubMed    


  543. DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1807.
    PubMed    


  544. ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1806-1807.
    PubMed    


  545. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.
    PubMed    


  546. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.
    PubMed    


  547. GENC K
    COVID-19 in Turkey: a nation on edge.
    Lancet. 2021;397:1794-1796.
    PubMed    


  548. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.
    PubMed    


  549. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    PubMed    


  550. HIMMELSTEIN DU, Woolhandler S
    Recovering from Trump: Biden's first 100 days.
    Lancet. 2021;397:1787-1791.
    PubMed    


  551. LIU STH, Aberg JA
    Convalescent plasma in patients hospitalised with COVID-19.
    Lancet. 2021 May 14. pii: S0140-6736(21)01064.
    PubMed    


  552. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.
    PubMed    


  553. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.
    PubMed    


  554. MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
    Disease surveillance for the COVID-19 era: time for bold changes.
    Lancet. 2021 May 14. pii: S0140-6736(21)01096.
    PubMed    



  555. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00897.
    PubMed     Abstract available


  556. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
    Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Lancet. 2021 May 12. pii: S0140-6736(21)00894.
    PubMed    


  557. SHAW RH, Stuart A, Greenland M, Liu X, et al
    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Lancet. 2021 May 12. pii: S0140-6736(21)01115.
    PubMed    


  558. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    PubMed    


  559. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.
    PubMed    


  560. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.
    PubMed    


  561. FUJIWARA Y, Onda Y, Hayashi S
    No-fault compensation schemes for COVID-19 medical products.
    Lancet. 2021;397:1707-1708.
    PubMed    


  562. HE S, Bala R, Anupindi R, Ranney ML, et al
    Effective supply chain surveillance for PPE.
    Lancet. 2021;397:1706-1707.
    PubMed    


  563. DEVI S
    COVID-19 surge threatens health in the Gaza strip.
    Lancet. 2021;397:1698.
    PubMed    


  564. THE LANCET
    India's COVID-19 emergency.
    Lancet. 2021;397:1683.
    PubMed    


  565. MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
    Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Lancet. 2021;397:1711-1724.
    PubMed     Abstract available


  566. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.
    PubMed    


  567. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.
    PubMed    


  568. ZAROCOSTAS J
    UK makes massive global health cuts.
    Lancet. 2021;397:1697.
    PubMed    


  569. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.
    PubMed    


  570. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.
    PubMed    


  571. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.
    PubMed    


  572. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.
    PubMed    



  573. Priorities for COVID-19 research response and preparedness in low-resource settings.
    Lancet. 2021 May 6. pii: S0140-6736(21)00980.
    PubMed    


  574. ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
    LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
    Lancet. 2021 May 6. pii: S0140-6736(21)00232.
    PubMed    


  575. CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
    What is the right level of spending needed for health and care in the UK?
    Lancet. 2021 May 6. pii: S0140-6736(21)00230.
    PubMed     Abstract available


  576. ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
    Securing a sustainable and fit-for-purpose UK health and care workforce.
    Lancet. 2021 May 6. pii: S0140-6736(21)00231.
    PubMed     Abstract available


  577. MCKEE M, Dunnell K, Anderson M, Brayne C, et al
    The changing health needs of the UK population.
    Lancet. 2021 May 6. pii: S0140-6736(21)00229.
    PubMed     Abstract available


  578. LESHEM E, Wilder-Smith A
    COVID-19 vaccine impact in Israel and a way out of the pandemic.
    Lancet. 2021 May 5. pii: S0140-6736(21)01018.
    PubMed    


  579. HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
    Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Lancet. 2021 May 5. pii: S0140-6736(21)00947.
    PubMed     Abstract available


  580. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.
    PubMed    


  581. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.
    PubMed    


  582. FOGSTAD H
    Women, children, and adolescents in the post-pandemic world.
    Lancet. 2021;397:1620.
    PubMed    


  583. HYDE R
    Controversy surrounds Merkel's new lockdown powers.
    Lancet. 2021;397:1610.
    PubMed    



  584. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021;397:1637-1645.
    PubMed     Abstract available


    April 2021
  585. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
    Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
    PubMed    


  586. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.
    PubMed    


  587. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.
    PubMed    


  588. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.
    PubMed    


  589. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.
    PubMed    


  590. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.
    PubMed    


  591. THE LANCET
    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.
    PubMed    


  592. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.
    PubMed    


  593. RASANATHAN K
    Global health and its discontents.
    Lancet. 2021;397:1543-1544.
    PubMed    


  594. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
    PubMed    


  595. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    PubMed     Abstract available


  596. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
    PubMed    


  597. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
    PubMed    


  598. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.
    PubMed    


  599. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
    PubMed    


  600. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
    PubMed    


  601. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    PubMed    


  602. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
    PubMed    


  603. ZAROCOSTAS J
    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    PubMed    


  604. THE LANCET
    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    PubMed    


  605. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.
    PubMed    


  606. CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
    The ultra-connected generation would like to disconnect now.
    Lancet. 2021;397:1350.
    PubMed    


  607. ANDREWS K
    Racism is the public health crisis.
    Lancet. 2021;397:1342-1343.
    PubMed    


  608. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
    PubMed    


  609. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    PubMed     Abstract available


  610. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
    PubMed    


  611. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    PubMed    


  612. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    PubMed    


  613. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    PubMed    


  614. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    PubMed    


  615. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    PubMed     Abstract available


  616. HE S, Lai D, Lee J
    The medical right to repair: the right to save lives.
    Lancet. 2021;397:1260-1261.
    PubMed    


  617. SAMARASEKERA U
    New EU health programme comes into force.
    Lancet. 2021;397:1252-1253.
    PubMed    


  618. JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
    10 years of the Syrian conflict: a time to act and not merely to remember.
    Lancet. 2021;397:1245-1248.
    PubMed    


  619. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
    PubMed    


    March 2021
  620. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    PubMed     Abstract available


  621. SANDERS RW, de Jong MD
    Pandemic moves and countermoves: vaccines and viral variants.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
    PubMed    


  622. MYLAN S, Hardman C
    COVID-19, cults, and the anti-vax movement.
    Lancet. 2021;397:1181.
    PubMed    


  623. THE LANCET
    COVID-19: building a stronger Europe.
    Lancet. 2021;397:1157.
    PubMed    


  624. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.
    PubMed    


  625. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
    PubMed    


  626. KLUGE H, McKee M
    COVID-19 vaccines for the European region: an unprecedented challenge.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
    PubMed    



  627. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    PubMed    


  628. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    PubMed    


  629. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    PubMed    


  630. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    PubMed    


  631. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    PubMed    


  632. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    PubMed    


  633. STRUGNELL R, Wang N
    Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
    Lancet. 2021;397:1037-1039.
    PubMed    


  634. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
    COVID-19, community trials, and inclusion.
    Lancet. 2021;397:1036-1037.
    PubMed    


  635. HE Z, Ren L, Yang J, Guo L, et al
    Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    Lancet. 2021;397:1075-1084.
    PubMed     Abstract available


  636. JAFFE S
    Biden's first legislative victory: $1.9 trillion for COVID-19.
    Lancet. 2021;397:1047-1048.
    PubMed    


  637. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.
    PubMed    


  638. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    PubMed    


  639. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    PubMed    


  640. BOYTON RJ, Altmann DM
    Risk of SARS-CoV-2 reinfection after natural infection.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
    PubMed    


  641. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    PubMed    


  642. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    PubMed    


  643. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
    PubMed    


  644. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    PubMed    


  645. THE LANCET
    Access to COVID-19 vaccines: looking beyond COVAX.
    Lancet. 2021;397:941.
    PubMed    


  646. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    PubMed    


  647. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    PubMed    


  648. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    PubMed    


  649. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
    PubMed    


  650. HUNG IFN, Poland GA
    Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
    Lancet. 2021;397:854-855.
    PubMed    


  651. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    PubMed    


  652. SAMARASEKERA U
    Robin Shattock: novel vaccine developer.
    Lancet. 2021;397:870.
    PubMed    


  653. SROUR SA
    Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
    Lancet. 2021;397:861-862.
    PubMed    


  654. SOE ZW, Oo MM, Wah KS, Naing AT, et al
    Myanmar's health leaders stand against military rule.
    Lancet. 2021;397:875.
    PubMed    


  655. MADAD S, Spencer C
    The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
    PubMed    


  656. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    PubMed     Abstract available



  657. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    PubMed     Abstract available


    February 2021
  658. CHAUVIN L
    Peruvian COVID-19 vaccine scandal spreads.
    Lancet. 2021;397:783.
    PubMed    


  659. ZAROCOSTAS J
    New WTO leader faces COVID-19 challenges.
    Lancet. 2021;397:782.
    PubMed    


  660. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    PubMed    


  661. MANISTY C, Otter AD, Treibel TA, McKnight A, et al
    Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
    PubMed    


  662. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    PubMed    


  663. WHITAKER DK
    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    PubMed    


  664. GODDARD AF, Patel M
    The changing face of medical professionalism and the impact of COVID-19.
    Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
    PubMed    


  665. SIVA N
    Severe mental illness: reassessing COVID-19 vaccine priorities.
    Lancet. 2021;397:657.
    PubMed    


  666. HYDE R
    von der Leyen admits to COVID-19 vaccine failures.
    Lancet. 2021;397:655-656.
    PubMed    


  667. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    PubMed    


  668. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    PubMed    


  669. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    PubMed    


  670. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    PubMed     Abstract available


  671. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    PubMed    


  672. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    PubMed    


  673. ROBERTSON JFR, Sewell HF, Stewart M
    Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
    PubMed    


  674. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    PubMed    


  675. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    PubMed    


  676. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    PubMed     Abstract available


  677. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    PubMed     Abstract available


  678. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
    PubMed    


  679. SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
    Future scenarios for the COVID-19 pandemic.
    Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
    PubMed    


  680. MAKONI M
    Tanzania refuses COVID-19 vaccines.
    Lancet. 2021;397:566.
    PubMed    


  681. BERWANGER O
    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.
    PubMed    


  682. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    PubMed    


  683. SINGH NS, Lokot M, Undie CC, Onyango MA, et al
    Research in forced displacement: guidance for a feminist and decolonial approach.
    Lancet. 2021;397:560-562.
    PubMed    


  684. THE LANCET
    Improving prisoner health for stronger public health.
    Lancet. 2021;397:555.
    PubMed    



  685. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
    PubMed    


  686. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
    Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
    PubMed     Abstract available


  687. FONTANET A, Autran B, Lina B, Kieny MP, et al
    SARS-CoV-2 variants and ending the COVID-19 pandemic.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
    PubMed    


  688. MARTIN S, Arawi T
    Ensure Palestinians have access to COVID-19 vaccines.
    Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
    PubMed    


  689. BURKI T
    Understanding variants of SARS-CoV-2.
    Lancet. 2021;397:462.
    PubMed    


  690. ZAROCOSTAS J
    WHO team begins COVID-19 origin investigation.
    Lancet. 2021;397:459.
    PubMed    


  691. GORNA R, MacDermott N, Rayner C, O'Hara M, et al
    Long COVID guidelines need to reflect lived experience.
    Lancet. 2021;397:455-457.
    PubMed    


  692. WARRELL MJ
    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.
    PubMed    


  693. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.
    PubMed    


  694. THE LANCET
    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.
    PubMed    


  695. CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
    A COVID-19 jab in the right direction.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
    PubMed    


  696. KAMPF G, Kulldorff M
    Calling for benefit-risk evaluations of COVID-19 control measures.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
    PubMed    


  697. MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
    Breastfeed or be vaccinated-an unreasonable default recommendation.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
    PubMed    


  698. JONES I, Roy P
    Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
    PubMed    


  699. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
    PubMed     Abstract available



  700. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
    PubMed     Abstract available


  701. FRIESEN P, Caplan AL, Miller JE
    COVID-19 vaccine research and the trouble with clinical equipoise.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
    PubMed    


  702. TUYISENGE G, Goldenberg SM
    COVID-19, structural racism, and migrant health in Canada.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
    PubMed    


    January 2021
  703. MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
    SARS-CoV-2 serosurveys in low-income and middle-income countries.
    Lancet. 2021;397:353-355.
    PubMed    


  704. SAMARASEKERA U
    Fransisca Handy Agung: improving adolescent health in Indonesia.
    Lancet. 2021;397:365.
    PubMed    


  705. DANIELS JP
    Health experts slam Bolsonaro's vaccine comments.
    Lancet. 2021;397:361.
    PubMed    


  706. THE LANCET
    Health and care workers are owed a better future.
    Lancet. 2021;397:347.
    PubMed    


  707. HALLAL PC
    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.
    PubMed    


  708. BLAKNEY AK, McKay PF
    Next-generation COVID-19 vaccines: here come the proteins.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
    PubMed    


  709. RICHMOND P, Hatchuel L, Dong M, Ma B, et al
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
    PubMed     Abstract available


  710. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
    PubMed    



  711. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
    PubMed    


  712. SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
    Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
    Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
    PubMed    


  713. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    PubMed    


  714. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    Lancet. 2021;397:277-278.
    PubMed    


  715. NASRALLAH MP, Mourelatos Z, Lee EB
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:277.
    PubMed    


  716. GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276.
    PubMed    


  717. EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276-277.
    PubMed    


  718. AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
    Reaffirming health and safety precautionary principles for COVID-19 in the UK.
    Lancet. 2021;397:274.
    PubMed    


  719. MAKONI M
    South Africa responds to new SARS-CoV-2 variant.
    Lancet. 2021;397:267.
    PubMed    


  720. BHUYAN A
    India begins COVID-19 vaccination amid trial allegations.
    Lancet. 2021;397:264.
    PubMed    


  721. THE LANCET
    COVID-19: the intersection of education and health.
    Lancet. 2021;397:253.
    PubMed    


  722. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    PubMed    


  723. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    PubMed    


  724. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    PubMed    


  725. PATEL MS, Phillips CB
    COVID-19 and the moral imagination.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
    PubMed    


  726. PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
    An action plan for pan-European defence against new SARS-CoV-2 variants.
    Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
    PubMed    


  727. IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
    Preparing for a COVID-19 resurgence in the WHO African region.
    Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
    PubMed    


  728. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    PubMed    


  729. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    PubMed    


  730. WEBSTER P
    COVID-19 highlights Canada's care home crisis.
    Lancet. 2021;397:183.
    PubMed    


  731. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    PubMed    


  732. JAFFE S
    New leadership at the US CDC.
    Lancet. 2021;397:182.
    PubMed    


  733. THE LANCET
    An opportunity for American renewal.
    Lancet. 2021;397:171.
    PubMed    


  734. CAVALERI M, Enzmann H, Straus S, Cooke E, et al
    The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
    Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
    PubMed    


  735. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    PubMed    


  736. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    PubMed    


  737. KUSIN S, Choo E
    Parenting in the time of COVID-19.
    Lancet. 2021;397:86.
    PubMed    


  738. USHER AD
    Health systems neglected by COVID-19 donors.
    Lancet. 2021;397:83.
    PubMed    


  739. KNEEBONE R, Schlegel C
    Thinking across disciplinary boundaries in a time of crisis.
    Lancet. 2021;397:89-90.
    PubMed    


  740. COUSINS S
    Polio in Afghanistan: a changing landscape.
    Lancet. 2021;397:84-85.
    PubMed    


  741. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
    Lancet. 2021;397:129-170.
    PubMed     Abstract available


  742. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    PubMed    


  743. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    PubMed     Abstract available


  744. THE LANCET
    Health as a foundation for society.
    Lancet. 2021;397:1.
    PubMed    


  745. DEVI S
    2021: a year of humanitarian need.
    Lancet. 2021;397:12-13.
    PubMed    


  746. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.
    PubMed    


  747. KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
    Germany's new global health strategy: leaving migrants behind.
    Lancet. 2021;397:20-21.
    PubMed    


  748. ROBERTS DE
    Abolish race correction.
    Lancet. 2021;397:17-18.
    PubMed    


  749. ROCHON PA, Stall NM, Gurwitz JH
    Making older women visible.
    Lancet. 2021;397:21.
    PubMed    


    December 2020
  750. GOODMAN J, de Prudhoe K, Williams C
    UK COVID-19 public inquiry needed to learn lessons and save lives.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
    PubMed    


  751. CLAESON M, Hanson S
    COVID-19 and the Swedish enigma.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
    PubMed    


  752. HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
    COVID-19 vaccines and women's security.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
    PubMed    


  753. SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
    Infectivity of asymptomatic versus symptomatic COVID-19.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
    PubMed    


  754. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
    PubMed    


  755. WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
    Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
    PubMed    


  756. KUNG S, Doppen M, Black M, Hills T, et al
    Reduced mortality in New Zealand during the COVID-19 pandemic.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
    PubMed    


  757. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    PubMed    


  758. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.
    PubMed    


  759. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.
    PubMed    


  760. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.
    PubMed    


  761. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.
    PubMed    


  762. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.
    PubMed    


  763. THE LANCET
    Facing up to long COVID.
    Lancet. 2020;396:1861.
    PubMed    


  764. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    PubMed    


  765. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    PubMed    


  766. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    PubMed     Abstract available


  767. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.
    PubMed    


  768. THE LANCET
    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.
    PubMed    


  769. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    PubMed    


  770. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    PubMed    


  771. THE LANCET
    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    PubMed    


  772. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    PubMed     Abstract available


    November 2020
  773. HERNANDEZ JM
    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.
    PubMed    


  774. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.
    PubMed    


  775. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.
    PubMed    


  776. THE LANCET
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    PubMed    


  777. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    PubMed    


  778. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    PubMed    


  779. HILLS T, Kearns N, Kearns C, Beasley R, et al
    Influenza control during the COVID-19 pandemic.
    Lancet. 2020;396:1633-1634.
    PubMed    


  780. THE LANCET
    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.
    PubMed    


  781. GRIFFITHS C, Mitchell M, Burnand A
    More support needed for UK charity-funded medical research.
    Lancet. 2020;396:1616-1618.
    PubMed    


  782. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
    PubMed    


  783. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
    PubMed    


  784. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    PubMed     Abstract available


  785. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.
    PubMed    


  786. CHANDAN JS
    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    PubMed    


  787. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    PubMed    


  788. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    PubMed    


  789. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    PubMed    


  790. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    PubMed    


  791. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
    PubMed    


  792. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
    PubMed    


  793. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
    PubMed    


  794. KRIEGER N, Testa C, Hanage WP, Chen JT, et al
    US racial and ethnic data for COVID-19 cases: still missing in action.
    Lancet. 2020;396:e81.
    PubMed    


  795. COVIDSURG COLLABORATIVE
    Surgery during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:e79.
    PubMed    


  796. VUTHALURU S, Koliyadan SV, Kanniwadi SS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e78.
    PubMed    


  797. MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e77.
    PubMed    


  798. ALDERMAN J
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e76.
    PubMed    


  799. RODRIGUES J, Chan JK, Issa F
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e75.
    PubMed    


  800. SHANTHANNA H, Uppal V
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e74.
    PubMed    


  801. HAMID HKS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e73.
    PubMed    


  802. HUNG IF, Yuen KY
    Early triple antiviral therapy for COVID-19 - Authors' reply.
    Lancet. 2020;396:1488.
    PubMed    


  803. LEE N, Ison M, Dunning J
    Early triple antiviral therapy for COVID-19.
    Lancet. 2020;396:1487-1488.
    PubMed    


  804. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Lancet. 2020;396:1486-1487.
    PubMed    


  805. LODGE A
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1486.
    PubMed    


  806. CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1485-1486.
    PubMed    


  807. HOFFMANN C, Wolf E
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    PubMed    


  808. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Lancet. 2020;396:1484-1485.
    PubMed    


  809. GEORGE TP
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    PubMed    


  810. DZAU VJ, Balatbat C
    Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
    Lancet. 2020;396:1469-1471.
    PubMed    


  811. THE LANCET
    COVID-19 in Latin America: a humanitarian crisis.
    Lancet. 2020;396:1463.
    PubMed    


  812. BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
    Institutional versus home isolation to curb the COVID-19 outbreak.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
    PubMed    


  813. WILDER-SMITH A, Cook AR, Dickens BL
    Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
    PubMed    


  814. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
    PubMed    


  815. HOPKINS C, Smith B
    Widespread smell testing for COVID-19 has limited application.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
    PubMed    


  816. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Widespread smell testing for COVID-19 has limited application - Authors' reply.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
    PubMed    


    October 2020
  817. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.
    PubMed    


  818. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.
    PubMed    


  819. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.
    PubMed    


  820. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.
    PubMed    


  821. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.
    PubMed    


  822. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.
    PubMed    


  823. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.
    PubMed    


  824. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.
    PubMed    


  825. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.
    PubMed    


  826. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
    PubMed    


  827. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    PubMed    


  828. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    PubMed    


  829. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    PubMed    


  830. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    PubMed    


  831. THE LANCET
    Global health: time for radical change?
    Lancet. 2020;396:1129.
    PubMed    


  832. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    PubMed    


  833. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    PubMed    


  834. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    PubMed    


  835. WARD BJ, Makarkov A, Seguin A, Pillet S, et al
    Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18-64 years) and older adults (>/=65 years): two multicentre, randomised phase 3 trials.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32014.
    PubMed     Abstract available


  836. TREGONING JS
    First human efficacy study of a plant-derived influenza vaccine.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32010.
    PubMed    


  837. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    PubMed     Abstract available


  838. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    PubMed    


  839. BLUKACZ A, Cabieses B
    COVID-19: leaving no one behind in Latin America.
    Lancet. 2020;396:1070.
    PubMed    


  840. CHARLIER P, Varison L
    Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
    Lancet. 2020;396:1069-1070.
    PubMed    


  841. KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
    Cancer and COVID-19 - Authors' reply.
    Lancet. 2020;396:1067-1068.
    PubMed    


  842. MALEK AE, Raad II, Jabbour E
    Cancer and COVID-19.
    Lancet. 2020;396:1066-1067.
    PubMed    


  843. MORIS D, Tsilimigras DI, Schizas D
    Cancer and COVID-19.
    Lancet. 2020;396:1066.
    PubMed    


  844. GROSS R, Conzelmann C, Muller JA, Reister F, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1065-1066.
    PubMed    


  845. CUMMINGS MJ, O'Donnell MR
    Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Lancet. 2020;396:1064.
    PubMed    


  846. SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic.
    Lancet. 2020;396:1064-1065.
    PubMed    


  847. PIOVANI D, Bonovas S
    Study of critically ill patients with COVID-19 in New York City.
    Lancet. 2020;396:1064.
    PubMed    


  848. CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
    COVID-19, comics, and the visual culture of contagion.
    Lancet. 2020;396:1061-1063.
    PubMed    


  849. COUSINS S
    2.5 million more child marriages due to COVID-19 pandemic.
    Lancet. 2020;396:1059.
    PubMed    


  850. THE LANCET
    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    PubMed    


  851. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    PubMed    


  852. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    PubMed    


  853. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    PubMed    


  854. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
    PubMed    


  855. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
    PubMed    


  856. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
    PubMed    


  857. BOZORGMEHR K
    Power of and power over COVID-19 response guidelines.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
    PubMed    


  858. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    PubMed    



  859. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    PubMed     Abstract available


  860. DENING KH, Lloyd-Williams M
    Minimising long-term effect of COVID-19 in dementia care.
    Lancet. 2020;396:957-958.
    PubMed    


  861. WANG Y, Gu X, Xu J, Cao B, et al
    Remdesivir and COVID-19 - Authors' reply.
    Lancet. 2020;396:954.
    PubMed    


  862. WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
    Remdesivir and COVID-19.
    Lancet. 2020;396:953-954.
    PubMed    


  863. EDWARDS JK, Cole SR, Adimora AA
    Remdesivir and COVID-19.
    Lancet. 2020;396:953.
    PubMed    


  864. GLAUS MJ, Von Ruden S
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    PubMed    


  865. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    PubMed    


  866. THE LANCET
    Building a resilient NHS, for COVID-19 and beyond.
    Lancet. 2020;396:935.
    PubMed    


    September 2020
  867. CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
    Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
    PubMed    


  868. STRATHDEE SA, Davies SC, Marcelin JR
    Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
    PubMed    


  869. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.
    PubMed    


  870. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.
    PubMed    


  871. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.
    PubMed    


  872. JAFFE S
    Media reports reveal political interference at the US CDC.
    Lancet. 2020;396:875.
    PubMed    


  873. THE LANCET
    COVID-19 in India: the dangers of false optimism.
    Lancet. 2020;396:867.
    PubMed    


  874. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.
    PubMed    


  875. BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
    Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
    PubMed     Abstract available


  876. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    PubMed    


  877. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    PubMed     Abstract available


  878. HAN E, Tan MMJ, Turk E, Sridhar D, et al
    Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
    Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
    PubMed     Abstract available


  879. LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
    PubMed    


  880. BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
    PubMed    


  881. PEIRIS M, Leung GM
    What can we expect from first-generation COVID-19 vaccines?
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
    PubMed    


  882. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.
    PubMed    


  883. KLEINERT S, Horton R
    Preprints with The Lancet are here to stay.
    Lancet. 2020;396:805.
    PubMed    


  884. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    PubMed    


  885. GALEA S, Ettman CK, Abdalla SM
    Access to health care and the 2020 US election.
    Lancet. 2020;396:803-805.
    PubMed    



  886. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
    PubMed    


  887. SLIWA K, Yacoub M
    Catalysing the response to NCDI Poverty at a time of COVID-19.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
    PubMed    


  888. THE LANCET
    Global collaboration for health: rhetoric versus reality.
    Lancet. 2020;396:735.
    PubMed    


  889. OLDENBURG CE, Doan T
    Azithromycin for severe COVID-19.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
    PubMed    


  890. FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
    Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
    PubMed     Abstract available


  891. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
    PubMed    


  892. LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
    PubMed     Abstract available


    August 2020
  893. FISHER DA, Carson G
    Back to basics: the outbreak response pillars.
    Lancet. 2020;396:598.
    PubMed    


    April 2020
  894. CHENG KK, Lam TH, Leung CC
    Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity.
    Lancet. 2020 Apr 16. pii: S0140-6736(20)30918.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.